InvestmentMay 1, 2026, 04:04 PM
Avalyn Pharma Closes IPO, Raises $345M with Overallotment Exercise
AI Summary
Avalyn Pharma Inc. announced the closing of its initial public offering, including the full exercise of the underwriters' overallotment option. The company sold an aggregate of 19,166,667 shares of common stock at $18.00 per share, generating gross proceeds of $345 million. Avalyn's common stock is now listed on the Nasdaq Global Select Market under the ticker "AVLN".
Key Highlights
- Closed initial public offering (IPO).
- Sold 19,166,667 shares of common stock.
- IPO price was $18.00 per share.
- Gross proceeds from the offering totaled $345 million.
- Underwriters fully exercised overallotment option for 2,500,000 additional shares.
- Common stock listed on Nasdaq Global Select Market under "AVLN".